Goldman Sachs Group Inc Vericel Corp Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 241,802 shares of VCEL stock, worth $8.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241,802

Previous 371,486 34.91%

Holding current value

$8.84 Million

Previous $16.6 Million 37.93%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$37.92 - $45.7 $4.92 Million - $5.93 Million	-129,684 Reduced 34.91%	241,802 $10.3 Million
Q1 2025 May 09, 2025	BUY	$44.5 - $61.8 $1.97 Million - $2.74 Million	44,333 Added 13.55%	371,486 $16.6 Million
Q4 2024 Feb 11, 2025	BUY	$40.05 - $59.11 $5.04 Million - $7.44 Million	125,949 Added 62.6%	327,153 $18 Million
Q3 2024 Nov 14, 2024	BUY	$42.25 - $53.56 $2.02 Million - $2.56 Million	47,742 Added 31.11%	201,204 $8.5 Million
Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $1.71 Million - $2.16 Million	-40,895 Reduced 21.04%	153,462 $7.04 Million
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $9.04 Million - $14.5 Million	-277,838 Reduced 58.84%	194,357 $10.1 Million
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $332,532 - $399,793	-10,779 Reduced 2.23%	472,195 $16.8 Million
Q3 2023 May 14, 2024	BUY	$31.69 - $39.25 $341,586 - $423,075	10,779 Added 2.28%	482,974 $16.2 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $6.9 Million - $8.55 Million	217,731 Added 82.09%	482,974 $16.2 Million
Q2 2023 May 14, 2024	SELL	$29.0 - $38.37 $336,690 - $445,475	-11,610 Reduced 4.19%	265,243 $9.97 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $336,690 - $445,475	-11,610 Reduced 4.19%	265,243 $9.97 Million
Q1 2023 May 14, 2024	BUY	$23.85 - $31.34 $2.08 Million - $2.73 Million	87,099 Added 45.9%	276,853 $8.12 Million
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $2.08 Million - $2.73 Million	87,099 Added 45.9%	276,853 $8.12 Million
Q4 2022 May 14, 2024	SELL	$17.65 - $27.37 $468,007 - $725,742	-26,516 Reduced 12.26%	189,754 $5 Million
Q4 2022 Feb 13, 2023	SELL	$17.65 - $27.37 $468,007 - $725,742	-26,516 Reduced 12.26%	189,754 $5 Million
Q3 2022 May 14, 2024	SELL	$22.62 - $32.54 $126,626 - $182,158	-5,598 Reduced 2.52%	216,270 $5.02 Million
Q3 2022 Nov 10, 2022	SELL	$22.62 - $32.54 $126,626 - $182,158	-5,598 Reduced 2.52%	216,270 $5.02 Million
Q2 2022 May 14, 2024	SELL	$22.88 - $39.45 $5.73 Million - $9.88 Million	-250,327 Reduced 53.01%	221,868 $5.59 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $402,527 - $694,043	17,593 Added 8.61%	221,868 $5.59 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $358,350 - $489,523	11,308 Added 5.86%	204,275 $7.81 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $2.3 Million - $3.44 Million	-65,418 Reduced 25.32%	192,967 $7.58 Million
Q3 2021 Nov 10, 2021	BUY	$46.35 - $59.75 $12 Million - $15.4 Million	258,385 New	258,385 $12.6 Million

Others Institutions Holding VCEL

# of Institutions

297

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.72B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Vericel Corp Transaction History